Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis
dc.contributor.author | Al Khleifat, Ahmad | |
dc.contributor.author | Iacoangeli, Alfredo | |
dc.contributor.author | van Vugt, Joke J F A | |
dc.contributor.author | Bowles, Harry | |
dc.contributor.author | Moisse, Matthieu | |
dc.contributor.author | Zwamborn, Ramona A J | |
dc.contributor.author | van der Spek, Rick A A | |
dc.contributor.author | Shatunov, Aleksey | |
dc.contributor.author | Cooper-Knock, Johnathan | |
dc.contributor.author | Topp, Simon | |
dc.contributor.author | Byrne, Ross | |
dc.contributor.author | Gellera, Cinzia | |
dc.contributor.author | López, Victoria | |
dc.contributor.author | Jones, Ashley R | |
dc.contributor.author | Opie-Martin, Sarah | |
dc.contributor.author | Vural, Atay | |
dc.contributor.author | Campos, Yolanda | |
dc.contributor.author | Van Rheenen, Wouter | |
dc.contributor.author | Kenna, Brendan | |
dc.contributor.author | van Eijk, Kristel R | |
dc.contributor.author | Kenna, Kevin | |
dc.contributor.author | Weber, Markus | |
dc.contributor.author | Smith, Bradley | |
dc.contributor.author | Fogh, Isabella | |
dc.contributor.author | Silani, Vincenzo | |
dc.contributor.author | Morrison, Karen E | |
dc.contributor.author | Dobson, Richard | |
dc.contributor.author | van Es, Michael A | |
dc.contributor.author | McLaughlin, Russell L | |
dc.contributor.author | Vourc'h, Patrick | |
dc.contributor.author | Chio, Adriano | |
dc.contributor.author | Corcia, Philippe | |
dc.contributor.author | de Carvalho, Mamede | |
dc.contributor.author | Gotkine, Marc | |
dc.contributor.author | Panades, Monica P | |
dc.contributor.author | Mora, Jesus S | |
dc.contributor.author | Shaw, Pamela J | |
dc.contributor.author | Landers, John E | |
dc.contributor.author | Glass, Jonathan D | |
dc.contributor.author | Shaw, Christopher E | |
dc.contributor.author | Basak, Nazli | |
dc.contributor.author | Hardiman, Orla | |
dc.contributor.author | Robberecht, Wim | |
dc.contributor.author | Van Damme, Philip | |
dc.contributor.author | van den Berg, Leonard H | |
dc.contributor.author | Veldink, Jan H | |
dc.contributor.author | Al-Chalabi, Ammar | |
dc.date.accessioned | 2023-07-10T12:26:44Z | |
dc.date.available | 2023-07-10T12:26:44Z | |
dc.date.issued | 2022-01-28 | |
dc.identifier.citation | Al Khleifat A, Iacoangeli A, van Vugt JJFA, Bowles H, Moisse M, Zwamborn RAJ, van der Spek RAA, Shatunov A, Cooper-Knock J, Topp S, Byrne R, Gellera C, López V, Jones AR, Opie-Martin S, Vural A, Campos Y, van Rheenen W, Kenna B, Van Eijk KR, Kenna K, Weber M, Smith B, Fogh I, Silani V, Morrison KE, Dobson R, van Es MA, McLaughlin RL, Vourc'h P, Chio A, Corcia P, de Carvalho M, Gotkine M, Panades MP, Mora JS, Shaw PJ, Landers JE, Glass JD, Shaw CE, Basak N, Hardiman O, Robberecht W, Van Damme P, van den Berg LH, Veldink JH, Al-Chalabi A. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis. NPJ Genom Med. 2022 Jan 28;7(1):8. doi: 10.1038/s41525-021-00267-9. PMID: 35091648; PMCID: PMC8799638. | en_US |
dc.identifier.eissn | 2056-7944 | |
dc.identifier.doi | 10.1038/s41525-021-00267-9 | en_US |
dc.identifier.pmid | 35091648 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/52263 | |
dc.description.abstract | There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | NPJ Genomic Medicine | en_US |
dc.relation.url | https://doi.org/10.1038/s41525-021-00267-9 | en_US |
dc.rights | Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/. © The Author(s) 2022 | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Amyotrophic lateral sclerosis | en_US |
dc.subject | Comparative genomics | en_US |
dc.title | Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis | en_US |
dc.type | Journal Article | en_US |
dc.source.journaltitle | NPJ genomic medicine | |
dc.source.volume | 7 | |
dc.source.issue | 1 | |
dc.source.beginpage | 8 | |
dc.source.endpage | ||
dc.source.country | United Kingdom | |
dc.source.country | United States | |
dc.source.country | United Kingdom | |
dc.source.country | United States | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | United Kingdom | |
dc.source.country | England | |
dc.identifier.journal | NPJ genomic medicine | |
refterms.dateFOA | 2023-07-10T12:26:46Z | |
dc.contributor.department | Neurology | en_US |